Security key
M96088105
UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)
CUSIP: M96088105
Q2 2018 13F Holders as of 30 Jun 2018
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.01 per share
- Total 13F shares
- 9,602,369
- Total 13F value
- $482,439,000
- Share change
- +472,929
- SEC-reported price per share
- $49.76
- Number of holders
- 60
- Value change
- +$24,129,548
- Number of buys
- 44
- Number of sells
- 17
- Shares outstanding
- 48,684,257
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2018
Institutions
60
Top holders
10
URGN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2018
Previous quarter: Q1 2018
UroGen Pharma Ltd. SEC filings
UroGen Pharma Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP M96088105
Recent filing periods:
Ownership snapshot
Top reported holders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
MENORA MIVTACHIM HOLDINGS...
Disclosed value leader
MENORA MIVTACHIM HOLDINGS...
Comparable rows
15/15
Latest evidence
31 Mar 2018
13F
Lead comparable stake: 4.2%
Showing 1-6 of 15 holder rows.
Quick read
MENORA MIVTACHIM HOLDINGS LTD. leads the comparable SEC ownership view at 4.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens MENORA MIVTACHIM HOLDINGS LTD.'s linked filing trail.
Comparable ownership
Top 5
MENORA MIVTACHIM HOLDINGS LTD.
4.2%
Consonance Capital Management LP
2.4%
ProQuest Associates IV LLC
2.3%
WELLINGTON MANAGEMENT GROUP LLP
1.9%
FMR LLC
1.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
4.2%
|
$101,647,000
2,045,629 shares
|
— | 31 Mar 2018 |
| Consonance Capital Management LP |
13F
Company
|
2.4%
|
$56,955,000
1,146,197 shares
|
— | 31 Mar 2018 |
| ProQuest Associates IV LLC |
13F
Company
|
2.3%
|
$54,461,000
1,096,024 shares
|
— | 31 Mar 2018 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
1.9%
|
$46,703,000
939,875 shares
|
— | 31 Mar 2018 |
| FMR LLC |
13F
Company
|
1.8%
|
$42,953,000
864,427 shares
|
— | 31 Mar 2018 |
| MEITAV INVESTMENT HOUSE LTD |
13F
Company
|
0.92%
|
$22,229,000
447,352 shares
|
— | 31 Mar 2018 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2018
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
60
Shares
9,602,369
Rows available
60
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2018 vs Q1 2018 Across Filers
Q1 2018 holders
43
Q2 2018 holders
60
Holder diff
17
| Investor | Q1 2018 Shares | Q2 2018 Shares | Share Diff | Share Chg % | Q1 2018 value | Q2 2018 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend